These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10897982)

  • 1. [Drug treatment of obsessive-compulsive disorder. With proper drugs and some patience many patients can be helped].
    Mavrogiorgou P; Hegerl U
    MMW Fortschr Med; 1999 Sep; 141(39):32-4, 37. PubMed ID: 10897982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic treatment of obsessive compulsive disorders.
    Jenike MA
    Psychiatr Clin North Am; 1992 Dec; 15(4):895-919. PubMed ID: 1461804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesis.
    McDougle CJ; Goodman WK; Leckman JF; Price LH
    Psychiatr Clin North Am; 1993 Dec; 16(4):749-66. PubMed ID: 8309811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
    Etain B; Bonnet-Perrin E
    Encephale; 2001; 27(3):280-9. PubMed ID: 11488259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy of obsessive-compulsive disorder.
    Jermain DM; Crismon ML
    Pharmacotherapy; 1990; 10(3):175-98. PubMed ID: 2196535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment.
    Saxena S; Maidment KM; Vapnik T; Golden G; Rishwain T; Rosen RM; Tarlow G; Bystritsky A
    J Clin Psychiatry; 2002 Jan; 63(1):21-7. PubMed ID: 11838621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of treatment-refractory obsessive compulsive disorder patients.
    Dominguez RA; Mestre SM
    J Clin Psychiatry; 1994 Oct; 55 Suppl():86-92. PubMed ID: 7961537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of efficacy of low doses of quetiapine addition in refractory obsessive-compulsive disorder.
    Sevincok L; Topuz A
    J Clin Psychopharmacol; 2003 Oct; 23(5):448-50. PubMed ID: 14520120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy of childhood obsessive-compulsive disorder.
    Leonard HL; Rapoport JL
    Psychiatr Clin North Am; 1989 Dec; 12(4):963-70. PubMed ID: 2690035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
    Kamijima K; Aoki M
    Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S; Harvey BH
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tourette's syndrome and treatment with clomipramine hydrochloride.
    Donahoe DH; Meador M; Fortune T; Llorena R
    W V Med J; 1991 Oct; 87(10):468-70. PubMed ID: 1767522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychopharmacologic treatment of child and adolescent obsessive compulsive disorder.
    Piacentini J; Jaffer M; Gitow A; Graae F; Davies SO; Del Bene D; Liebowitz M
    Psychiatr Clin North Am; 1992 Mar; 15(1):87-107. PubMed ID: 1549550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prospective follow-up over a 12 month period of a cohort of 155 patients with obsessive-compulsive disorder: phase III National DRT-TOC Study].
    Hantouche EG; Bouhassira M; Lancrenon S
    Encephale; 2000; 26(6):73-83. PubMed ID: 11217541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome.
    Perugi G; Toni C; Frare F; Travierso MC; Hantouche E; Akiskal HS
    J Clin Psychiatry; 2002 Dec; 63(12):1129-34. PubMed ID: 12523872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obsessive-compulsive disorder.
    George MS
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():57-66; discussion 66-8. PubMed ID: 1806635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological treatment of obsessive-compulsive disorder.
    Pittenger C; Bloch MH
    Psychiatr Clin North Am; 2014 Sep; 37(3):375-91. PubMed ID: 25150568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches to the patient with treatment-refractory obsessive compulsive disorder.
    Jenike MA
    J Clin Psychiatry; 1990 Feb; 51 Suppl():15-21. PubMed ID: 2404966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of obsessive-compulsive disorders.
    Murray JB
    Genet Soc Gen Psychol Monogr; 1986 May; 112(2):173-99. PubMed ID: 2875011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.